Immatics (IMTX) Revenue - Other (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue - Other (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Immatics | 1.80 Bn | 1.80 Bn | - | 5.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.43 Mn |
| Sep 30, 2025 | 33,902.60 |
| Jun 30, 2025 | 24,903.11 |
| Mar 31, 2025 | 19,985.80 |
| Dec 31, 2024 | 25,646.29 |
| Sep 30, 2024 | 18,669.73 |
| Jun 30, 2024 | 26,922.19 |
| Mar 31, 2024 | 13,036.34 |
| Dec 31, 2023 | 5,379.70 |
| Sep 30, 2023 | 202,477.83 |
| Jun 30, 2023 | 6,533.55 |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | -16,323.96 |
| Sep 30, 2022 | 9,074.47 |
| Jun 30, 2022 | 28,810.53 |
| Mar 31, 2022 | 7,856.36 |
| Dec 31, 2021 | 16,015.59 |
| Sep 30, 2021 | 55,426.50 |
| Jun 30, 2021 | 31,311.06 |
| Mar 31, 2021 | 288,290.43 |
| Dec 31, 2020 | 84,652.58 |
| Sep 30, 2020 | 37,378.47 |
| Jun 30, 2020 | 94,725.57 |
| Mar 31, 2020 | 124,745.11 |
| Dec 31, 2019 | 77,482.14 |
| Sep 30, 2019 | 211,418.71 |
| Jun 30, 2019 | 138,207.61 |